Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.21p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.22
  • 52 Week Low: 0.20
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 18,500
  • Market Cap: £4.51m

Company Description

Clinical stage drug development company.

IPO Details

Issue Date 21-Oct-2015 Prospectus n/a
Issue Price n/a Lead Broker n/a
Market Cap £0.00m Contact Tel +44 (0) 20 7466 5000
Method Introduction    
Sector Pharmaceuticals    
Market Aim    
Amount Raised £20,000,000.00m    

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.21p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.22
52 Week Low 0.20
Volume 18,500
Shares Issued 2,148.96m
Market Cap £4.51m

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
13.79% above the market average13.79% above the market average13.79% above the market average13.79% above the market average13.79% above the market average
90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average
Price Trend
86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average86.93% below the market average
72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average72.73% below the sector average
Income Not Available
Growth Not Available

Theracryf Dividends

No dividends found

Trades for 24-Oct-2025

Time Volume / Share Price
11:00 18,500 @ 0.22p
11:00 18,500 @ 0.22p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page